Bibliografia
Haugen BR, Alexander EK, Bible KC et al. (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133
Miyauchi A, Kudo T, Miya A et al. (2011) Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid 21:707–716
Laure Giraudet A, Al Ghulzan A, Aupérin A et al. (2008) Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. Eur J Endocrinol 158:239–246
Pupilli C, Pinzani P, Salvianti F et al. (2013) Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 98(8):3359–3365
Malara N, Givigliano F, Trunzo V et al. (2014) In vitro expansion of tumour cells derived from blood and tumour tissue is useful to redefine personalized treatment in non-small cell lung cancer patients. J Biol Reg Homeos Ag 28(4):717–731
Malara N, Trunzo V, Foresta U et al. (2016) Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment. J Transl Med 14(1):133
Malara N, Guzzi G, Mignogna C et al. (2016) Non-invasive real-time biopsy of intracranial lesions using short time expanded circulating tumor cells on glass slide: report of two cases. BMC Neurol 16(1):127
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflitto di interesse
Gli autori Natalia Malara, Nadia Innaro, Chiara Mignogna, Ivan Presta, Krizia Caterina Pirrone, Annalidia Donato, Vincenzo Gangemi, Rosario Sacco, Vincenzo Mollace e Giuseppe Donato dichiarano di non avere conflitti di interesse.
Consenso informato
La paziente, previo colloquio informativo, ha firmato il consenso informato del progetto CHARACTEX, approvato dal comitato etico “Mater Domini” con il numero 2013.34. Successivamente alla sua adesione firmata è stata sottoposta a prelievo di sangue periferico (volume totale 5 ml). Il consenso informato firmato è incluso come materiale supplementare. La firma della paziente è stata coperta nel rispetto della legge italiana sulla privacy (art. 7, 196/03).
Studi sugli animali
Gli autori di questo articolo non hanno eseguito studi sugli animali.
Rights and permissions
About this article
Cite this article
Malara, N., Innaro, N., Mignogna, C. et al. La biopsia liquida nella diagnosi del carcinoma tiroideo indifferenziato. L'Endocrinologo 19, 270–272 (2018). https://doi.org/10.1007/s40619-018-00488-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-018-00488-8